

新聞中心
時間:2025-07-22 10:12:37 來源:本站
在醫藥研發邁向智能化、數字化的浪潮中,技術驅動已成為提升效率與保障質量的關鍵。
2025年6月,國際去中心化臨床試驗(DCT)解決方案先鋒——信華醫藥(Xincere),與全球領先的臨床試驗移動設備定制專家——Inventus,正式達成戰略合作。
Embracing Intelligent, Digital-Driven R&D: Xincere and Inventus Announce Strategic Partnership. As the pharmaceutical industry moves toward intelligent, digital-driven research and development, technology has become key to boosting efficiency and ensuring quality. In June 2025, DCT pioneer Xincere and global leader in custom clinical-trial devices Inventus officially entered into a strategic partnership, ushering in a new era of smart clinical-trial equipment.
此次戰略合作,正是雙方優勢的完美契合,聚焦四大核心領域 Four Pillars of Our Partnership:

01 海外尖端設備引進與深度定制化 Deep-Customizing Advanced Overseas Device
信華醫藥將依托Inventus強大的全球資源網絡和頂尖工程能力,引入其高品質的海外研發與生產設備。更為關鍵的是,Inventus的“深度定制化”基因將在此次合作中充分展現,雙方將共同設計開發專用設備解決方案。
Xincere will leverage Inventus’s global resource network and engineering expertise to bring in high-quality, overseas-developed devices. Crucially, Inventus’s DNA of “deep customization” will shine as both companies co-design and develop dedicated clinical-trial hardware tailored to China’s diverse trial scenarios.
02 本土化MDM軟件方案賦能研發數據治理 Localizing MDM for Robust Data Governance
面對國內日益嚴格的醫藥研發數據規范高要求,雙方將共同推進Inventus先進的移動設備管理(MDM)軟件解決方案在國內醫藥研發場景的落地與優化。
In response to China’s ever-tightening regulations on R&D data integrity, the partners will jointly implement and optimize Inventus’s advanced mobile device management (MDM) software in local trial settings—enabling precise control over device lifecycles, patient data, and protocol compliance.
03 全球eSIM連接保障 End-to-End Global eSIM Connectiv
依托Inventus廣泛的全球運營商合作網絡,雙方將為臨床試驗設備提供內置eSIM解決方案,確保在多中心、多國家環境下實現無縫漫游和穩定數據傳輸,為試驗數據的實時性和完整性保駕護航。
Tapping into Inventus’s extensive partnerships with network operators worldwide, the collaboration will embed eSIM technology in trial devices—guaranteeing seamless roaming and stable data transmission across multiple centers and countries, thereby safeguarding real-time data flow and completeness.
04 共繪未來臨床試驗智能設備藍圖 Next Generation of Smart Trial Devices
基于對當前國內臨床試驗設備應用現狀,痛點(如設備便攜性不足、續航焦慮、數據實時性差、環境適應性弱、管理困難等)以及未來需求的深入交流,信華醫藥與Inventus將攜手探索和定義下一代智能化臨床試驗設備的理想形態。
Building on an in-depth exchange about current domestic device challenges—portability, battery life, data latency, environmental resilience, and management complexity—Xincere and Inventus will jointly explore and define the ideal form factor for next-generation smart clinical-trial equipment.
此次信華醫藥與Inventus的強強聯手,是基于共同愿景的技術與產業的深度融合。雙方將以本次戰略合作為起點,持續深化在技術研發、設備優化、數據治理及未來應用場景探索等層面的協同創新,共同推動醫藥研發向更智能、更高效、更合規的方向加速發展。
This alliance between Xincere and Inventus is a deep fusion of shared vision, technology, and industry expertise. As a starting point, both companies will continue to drive co-innovation in R&D, device optimization, data governance, and emerging trial scenarios—together propelling pharmaceutical R&D toward a smarter, more efficient, and rigorously compliant future.
? 信華醫藥(Xincere):全球領先的去中心化臨床試驗(DCT)平臺解決方案供應商,專注于開發以患者為中心的遠程智能臨床試驗平臺。通過將數字技術與人工智能應用于臨床試驗,Xincere致力于提升臨床試驗的可及性、減輕患者負擔、提高臨床研究質量與效率,并降低藥物研發成本。
About Xincere
Xincere is a global frontrunner in decentralized clinical-trial (DCT) platforms, dedicated to building patient-centric, remote-enabled smart trial solutions. By integrating digital technologies and artificial intelligence into clinical research, Xincere enhances trial accessibility, reduces patient burden, improves data quality and operational efficiency, and drives down drug-development costs.
? Inventus:專注于臨床試驗支持的科技型企業,作為全球唯一聚焦于臨床研究設備的OEM制造商,提供覆蓋全生命周期的一站式智能終端解決方案,涵蓋設備定制、遠程管理、全球部署與綠色回收。通過結合前沿技術與臨床實際需求,Inventus致力于構建安全、高效、可持續的設備交付與管理體系,助力制藥企業與CRO加速臨床試驗進程,提升數據質量,推動創新藥物更快惠及患者。
About Inventus
Inventus is the world’s only OEM manufacturer solely devoted to clinical-trial devices, offering a one-stop, end-to-end smart-terminal solution across the entire product lifecycle—device customization, remote management, global eSIM deployment, and green recycling. By marrying cutting-edge technology with real-world trial needs, Inventus creates secure, efficient, and sustainable device delivery and management systems that help pharmaceutical companies and CROs accelerate trials, elevate data integrity, and bring innovative therapies to patients faster.